These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 18690166)

  • 1. Estrogen receptor gene amplification occurs rarely in ovarian cancer.
    Issa RM; Lebeau A; Grob T; Holst F; Moch H; Terracciano L; Choschzick M; Sauter G; Simon R
    Mod Pathol; 2009 Feb; 22(2):191-6. PubMed ID: 18690166
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Grb7 gene amplification and protein expression by FISH and IHC in ovarian cancer.
    Zeng M; Yang Z; Hu X; Liu Y; Yang X; Ran H; Li Y; Li X; Yu Q
    Int J Clin Exp Pathol; 2015; 8(9):11296-304. PubMed ID: 26617853
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gene amplification and protein overexpression of MET are common events in ovarian clear-cell adenocarcinoma: their roles in tumor progression and prognostication of the patient.
    Yamamoto S; Tsuda H; Miyai K; Takano M; Tamai S; Matsubara O
    Mod Pathol; 2011 Aug; 24(8):1146-55. PubMed ID: 21478826
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estrogen receptor alpha (ESR1) gene amplification is frequent in breast cancer.
    Holst F; Stahl PR; Ruiz C; Hellwinkel O; Jehan Z; Wendland M; Lebeau A; Terracciano L; Al-Kuraya K; Jänicke F; Sauter G; Simon R
    Nat Genet; 2007 May; 39(5):655-60. PubMed ID: 17417639
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Absence of estrogen receptor alpha (ESR1) gene amplification in a series of breast cancers in Taiwan.
    Chen JR; Hsieh TY; Chen HY; Yeh KY; Chen KS; ChangChien YC; Pintye M; Chang LC; Hwang CC; Chien HP; Hsu YC
    Virchows Arch; 2014 Jun; 464(6):689-99. PubMed ID: 24756215
    [TBL] [Abstract][Full Text] [Related]  

  • 6. EGFR gene amplification in breast cancer: correlation with epidermal growth factor receptor mRNA and protein expression and HER-2 status and absence of EGFR-activating mutations.
    Bhargava R; Gerald WL; Li AR; Pan Q; Lal P; Ladanyi M; Chen B
    Mod Pathol; 2005 Aug; 18(8):1027-33. PubMed ID: 15920544
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular characterization of mucinous ovarian tumours supports a stratified treatment approach with HER2 targeting in 19% of carcinomas.
    Anglesio MS; Kommoss S; Tolcher MC; Clarke B; Galletta L; Porter H; Damaraju S; Fereday S; Winterhoff BJ; Kalloger SE; Senz J; Yang W; Steed H; Allo G; Ferguson S; Shaw P; Teoman A; Garcia JJ; Schoolmeester JK; Bakkum-Gamez J; Tinker AV; Bowtell DD; Huntsman DG; Gilks CB; McAlpine JN
    J Pathol; 2013 Jan; 229(1):111-20. PubMed ID: 22899400
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Invasive ductal carcinoma of the breast: study of the number of copies of the CCND1 gene and chromosome 11 using fluorescence in situ hybridization (FISH) in comparison with expression of cyclin D1 protein and estrogen receptors (ER alpha) with immunohistochemical detection].
    Mrhalová M; Kodet R; Strnad P
    Cas Lek Cesk; 2002 Nov; 141(22):708-14. PubMed ID: 12532908
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oestrogen receptor gene (ESR1) amplification is frequent in endometrial carcinoma and its precursor lesions.
    Lebeau A; Grob T; Holst F; Seyedi-Fazlollahi N; Moch H; Terracciano L; Turzynski A; Choschzick M; Sauter G; Simon R
    J Pathol; 2008 Oct; 216(2):151-7. PubMed ID: 18720455
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical significance of ESR1 gene copy number changes in breast cancer as measured by fluorescence in situ hybridisation.
    Lin CH; Liu JM; Lu YS; Lan C; Lee WC; Kuo KT; Wang CC; Chang DY; Huang CS; Cheng AL
    J Clin Pathol; 2013 Feb; 66(2):140-5. PubMed ID: 23268322
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytokeratin 5/6 expression, prognosis, and association with estrogen receptor α in high-grade serous ovarian carcinoma.
    Taube ET; Denkert C; Sehouli J; Unger U; Kunze CA; Budczies J; Dietel M; Braicu E; Darb-Esfahani S
    Hum Pathol; 2017 Sep; 67():30-36. PubMed ID: 28414091
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessing the impact of polysomy-17 on HER2 status and the correlations of HER2 status with prognostic variables (ER, PR, p53, Ki-67) in epithelial ovarian cancer: a tissue microarray study using immunohistochemistry and fluorescent in situ hybridization.
    Lin CK; Lin WL; Chen FL; Lee MY; Kuo JF; Ruan A; Tyan YS; Chiang H; Chou MC; Han CP
    Int J Gynecol Pathol; 2011 Jul; 30(4):372-9. PubMed ID: 21623202
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Actinin-4 gene amplification in ovarian cancer: a candidate oncogene associated with poor patient prognosis and tumor chemoresistance.
    Yamamoto S; Tsuda H; Honda K; Onozato K; Takano M; Tamai S; Imoto I; Inazawa J; Yamada T; Matsubara O
    Mod Pathol; 2009 Apr; 22(4):499-507. PubMed ID: 19151661
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Frequent homogeneous HER-2 amplification in primary and metastatic adenocarcinoma of the esophagus.
    Reichelt U; Duesedau P; Tsourlakis MCh; Quaas A; Link BC; Schurr PG; Kaifi JT; Gros SJ; Yekebas EF; Marx A; Simon R; Izbicki JR; Sauter G
    Mod Pathol; 2007 Jan; 20(1):120-9. PubMed ID: 17143264
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular clustering based on ERα and EIG121 predicts survival in high-grade serous carcinoma of the ovary/peritoneum.
    Schlumbrecht MP; Xie SS; Shipley GL; Urbauer DL; Broaddus RR
    Mod Pathol; 2011 Mar; 24(3):453-62. PubMed ID: 21102415
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Significance of estrogen receptor 1 (ESR-1) gene imbalances in colon and hepatocellular carcinomas based on tissue microarrays analysis.
    Tsiambas E; Georgiannos SN; Salemis N; Alexopoulou D; Lambropoulou S; Dimo B; Ioannidis I; Kravvaritis C; Karameris A; Patsouris E; Dourakis S
    Med Oncol; 2011 Dec; 28(4):934-40. PubMed ID: 20458558
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Status of estrogen receptor 1 (ESR1) gene in mastopathy predicts subsequent development of breast cancer.
    Soysal SD; Kilic IB; Regenbrecht CR; Schneider S; Muenst S; Kilic N; Güth U; Dietel M; Terracciano LM; Kilic E
    Breast Cancer Res Treat; 2015 Jun; 151(3):709-15. PubMed ID: 25981900
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ESR1 amplification is rare in breast cancer and is associated with high grade and high proliferation: a multiplex ligation-dependent probe amplification study.
    Moelans CB; Monsuur HN; de Pinth JH; Radersma RD; de Weger RA; van Diest PJ
    Anal Cell Pathol (Amst); 2010; 33(1):13-8. PubMed ID: 20966540
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pattern of HER-2 Gene Amplification and Protein Expression in Benign, Borderline, and Malignant Ovarian Serous and Mucinous Neoplasms.
    Mohammed RAA; Makboul R; Elsers DAH; Elsaba TMAM; Thalab AMAB; Shaaban OM
    Int J Gynecol Pathol; 2017 Jan; 36(1):50-57. PubMed ID: 27309616
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gene amplification in ductal carcinoma in situ of the breast.
    Burkhardt L; Grob TJ; Hermann I; Burandt E; Choschzick M; Jänicke F; Müller V; Bokemeyer C; Simon R; Sauter G; Wilczak W; Lebeau A
    Breast Cancer Res Treat; 2010 Oct; 123(3):757-65. PubMed ID: 20033484
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.